Detailled Information

Jones SD, Steiner A, Garrett SL, Calin A. The Bath Ankylosing Spondylitis Patient Global Score (BAS-G). Br J Rheumatol. 1996 Jan;35(1):66-71

The purpose of the present study was to examine the reproducibility of the indices in anti-TNF-treated SpA patients already familiar with the use of BASDAI, BASFI and BAS-G.

Establishment of the minimum clinically important difference for the bath ankylosing spondylitis indices.

Reproducibility of the Bath Ankylosing Spondylitis Indices of disease activity (BASDAI), functional status (BASFI) and overall well-being (BAS-G) in anti-tumour necrosis factor-treated spondyloarthropathy patients.

This study investigates the reliability and validity of the Turkish version of the BAS-G.

Portuguese version of the Bath indices for ankylosing spondylitis patients: a cross-cultural adaptation and validation

Defining disease status in ankylosing spondylitis: validation and cross-cultural adaptation of the Arabic Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and the Bath Ankylosing Spondylitis Global score (BASG) (Arabic).

Patient-completed tool used to give a global assessment of the well-being of the person with AS/axial SpA over a given time period.  The patient global assessment evaluates the impact of AS from the patients’ perspective. 

The BAS-G consists of two questions that ask patients’ to indicate the effect the disease has had on their well-being over the last week and last six months.

Each question represents a different timeframe and should be interpreted individually.

However, the two questions can to be added up. After having a total Score out of 20, itis divided by 2 to obtain an average, this is the BAS-G score.  The mean of the two scores gives a BAS-G score of 0 – 10.